Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bastard

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|March 1, 2005
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemiaA de Labarthe, C Pautas, X Thomas, et al.
Leukemia|July 1, 1996
Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locusM J Dyer, D M Lillington, C Bastard, et al.
Leukemia|July 11, 2008
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximabJ-P Jais, C Haioun, T J Molina, et al.
Leukemia & Lymphoma|March 28, 1998
PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des LeucémiesB Lenormand, M C Béné, J F Lesesve, et al.
Leukemia|January 23, 2009
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the diseaseF Jardin, M Callanan, D Penther, et al.
Leukemia|August 21, 2009
Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)I Nagel, S Bug, H Tönnies, et al.
Cancer Genetics and Cytogenetics|December 13, 2005
Cytogenetic study of 75 erythroleukemiasM Lessard, S Struski, V Leymarie, et al.
Leukemia|June 6, 2008
Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologiqueC Gervais, A Murati, C Helias, et al.
Leukemia|September 27, 2008
Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked casesA Murati, C Gervais, N Carbuccia, et al.
Leukemia|May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemiaE Chapiro, I Radford-Weiss, C Bastard, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|March 1, 2005
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemiaA de Labarthe, C Pautas, X Thomas, et al.
Leukemia|July 1, 1996
Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locusM J Dyer, D M Lillington, C Bastard, et al.
Leukemia|July 11, 2008
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximabJ-P Jais, C Haioun, T J Molina, et al.
Leukemia & Lymphoma|March 28, 1998
PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des LeucémiesB Lenormand, M C Béné, J F Lesesve, et al.
Leukemia|January 23, 2009
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the diseaseF Jardin, M Callanan, D Penther, et al.
Leukemia|August 21, 2009
Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)I Nagel, S Bug, H Tönnies, et al.
Cancer Genetics and Cytogenetics|December 13, 2005
Cytogenetic study of 75 erythroleukemiasM Lessard, S Struski, V Leymarie, et al.
Leukemia|June 6, 2008
Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologiqueC Gervais, A Murati, C Helias, et al.
Leukemia|September 27, 2008
Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked casesA Murati, C Gervais, N Carbuccia, et al.
Leukemia|May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemiaE Chapiro, I Radford-Weiss, C Bastard, et al.
Pageof 11